SNHG29 and laryngeal carcinoma: A recent study demonstrated that SNHG29 (small nucleolar RNA host gene 29) plays an important role in the invasion, migration, and epithelial-to-mesenchymal transition of laryngeal cancer, suggesting that SNHG29 is a potential therapeutic target [44].